Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has announced an update on its share buyback program, initiated on April 30, 2025, to support stock option and performance share plans for its management. Between August 11 and 15, 2025, the company purchased a total of 40,307 ordinary shares at a weighted average price of €50.5448 per share. As of August 15, 2025, Recordati holds 4,112,354 own shares, representing 1.966% of its share capital. This strategic move is expected to enhance the company’s operational flexibility and align management incentives with shareholder interests.
The most recent analyst rating on (IT:REC) stock is a Buy with a EUR61.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. Originating from a family-run pharmacy in Northern Italy in the 1920s, the company now offers therapeutic options in both general and specialist medicine, as well as rare diseases. Recordati integrates activities from clinical development to production, marketing, and licensing of active ingredients and finished products. The company operates in about 150 countries across EMEA, Americas, and APAC regions, employing over 4,580 people worldwide.
Average Trading Volume: 258,577
Technical Sentiment Signal: Buy
Current Market Cap: €10.57B
Learn more about REC stock on TipRanks’ Stock Analysis page.